The two-dose Sputnik V Covid-19 vaccine, which has been developed by Russia-based Gamaleya Institute, is the fourth to get Emergency Use Authorization in the Philippines

“The known and potential benefits of the Gamaleya Sputnik V vaccine outweigh the known and potential risks of the said vaccine,” FDA chief Rolando Enrique Domingo said at a news conference.

The Philippines has so far reported 648,066 confirmed coronavirus cases, with 12,900 deaths, and 561,902 recoveries.

The Philippines plans to buy 140.5 million vaccines by the end of this year in order to vaccinate 70 million adults.